View on market: Stay Cautious, be with quality business:
Asian stocks rose Thursday after progress on the U.S. debt-ceiling impasse lifted equities on Wall Street. Shares advanced in Japan, Australia and South Korea, while U.S. futures also climbed. The S&P 500 and Nasdaq 100 erased losses of more than 1% to close with gains on a possible deal to boost the debt ceiling into December. That would alleviate the immediate risk of a default but leave the political fight simmering in Washington. The Singapore-traded SGX Nifty, an early indicator of India’s Nifty 50 Index’s performance, rose 0.79%, to 17,767.00, as of 8:00 a.m.
Economic Calender:
- INR: Interest Rate Decision on 8th October, 2021.
- INR: Deposit & Bank Loan Growth on 8th October, 2021
- USD: Initial Job Claims on 7th October, 2021.
- USD: Unemployment Rate (Sept) & Nonfarm Payrolls (Sept) on 8th October, 2021.
Brokerage Radar:
CS ON TITAN: Maintain neutral at the price of Rs 2147 for the target price of Rs 2150. Jewellery growth in Q2 significantly ahead of expectations. Postponed demand from Q1 likely to have contributed. Increase our FY22/23/24 earnings estimates by 8%/5%/5.
CLSA ON CEMENT: Cost inflation, seasonal price softness weigh on profitability. Forecast a sharp drop (14% YoY) in India cement cos’ Q2 profitability. Volumes are likely to be resilient, with mid-single-digit YoY industry growth. We are in midst of a demand upcycle, but cost increases have been persistent. For FY22, we forecast about 12% volume growth & flat EBITDA/ YoY. We prefer ACC & UltraTech Cement Upgrade Ramco cements to outperform from underperform. Maintain outperform on Ambuja & Dalmia Bharat. Remain cautious on Shree cement, have underperform call.
International Markets:
U.S & Europe
| Particulars | 6th Oct | Chg | Chg(%) |
| Nasdaq | 14,501.91 | 68.08 | 0.47 |
| Dow | 34,416.99 | 102.32 | 0.32 |
| FTSE | 6,995.87 | -81.23 | -1.15 |
| CAC | 6,493.12 | -83.16 | -1.26 |
| DAX | 14,973.33 | -221.16 | -1.46 |
| Dow Fut.* | 34,457.00 | 166.00 | 0.48 |
Asian markets:
| Particulars | 7th Oct | Chg | Chg(%) |
| SGX Nifty | 17,767.00 | 138.50 | 0.79 |
| Nikkei | 27,990.32 | 461.45 | 1.68 |
| Straits Times | 3,114.40 | 30.52 | 0.99 |
| Hang Seng | 24,462.28 | 495.79 | 2.07 |
| Shanghai* | 3,568.17 | 31.88 | 0.90 |
ADR Watch:
| Particulars | 6th Oct | Chg | Chg(%) |
| Dr Reddy | 65.86 | -0.82 | -1.23 |
| HDFC Bank | 73.00 | -0.26 | -0.35 |
| ICICI Bank | 18.69 | -0.15 | -0.80 |
| Infosys | 22.45 | -0.30 | -1.32 |
| Tata Motor | 22.34 | -0.79 | -3.42 |
| Wipro | 8.80 | -0.15 | -1.68 |
Commodities & Currency
| Particulars | Current Price | Chg(%) |
| USD/INR | 75.17 | 0.66 |
| Brent | 80.59 | -0.60 |
| Gold | 1759.30 | -0.14 |
| Silver | 22.585 | 0.24 |
FIIs & DII
| Particulars | 6th Oct | 5th Oct |
| FIIs | -801.81 | -1915.08 |
| DIIs | -998.69 | 1868.23 |
News Update:
Zee Entertainment Enterprises: The founder of Zee Entertainment Enterprises Ltd., Subhash Chandra, has alleged that dissenting investors Invesco Developing Markets Fund and OFI Global China Fund LLC are trying to take over the firm he set up two decades ago, adding another twist in the public fight for board control of India’s largest listed TV network.
Nazara Technologies: The company raised Rs 315 crore from marquee institutional investors. The funds will be utilised to invest in growth initiatives of the company as well as pursue strategic acquisitions in the various business verticals of the company including gamified learning, freemium, skill based real money gaming and esports.
Lupin: Received tentative U.S. FDA approval for Brexpiprazole Tablets, a generic equivalent of Rexulti Tablets of Otsuka Pharmaceutical Co. The company will manufacture Brexpiprazole at its Pithampur facility in India.
Titan Company: Co. reported strong recovery in demand in Q2FY22. Jewellery business grew by 78% in Q2FY22 YoY & added 13 stores during the Q1, watches & wearables segment registered 73% YoY growth & eye wear business increased by 74% YoY in the same period.
Sobha: New sales grew by 50.62% to 13.48 lakh square feet in Q2FY22 versus 8.91 lakh square feet in Q2FY21. Total sales value increased 49.32% to Rs 1,030.2 crore from Rs 689.9 crore in the same period. The company achieved best-ever quarterly sales volume of 13.5 lakh square feet of super built-up area. It also achieved best ever Sobha Share of sale value of Rs 854 crore. Average cost of borrowing has further come down during the quarter.
Macrotech Developers: Q2 pre-sales rise 88% year-on-year to Rs 2,003 crore. The company had pre-sales of £145 million (Rs 1,450 crore) in U.K. projects during the quarter. Collections up 73% YoY at Rs 1,912 crore. Net debt at India business fell to Rs 12,508 crore versus Rs 16,965 crore a year earlier. Plans to cut debt to about Rs 10,000 crore by March.
Telecom stocks:Govt has reduced bank guarantee requirement for telecom operators by 80%.
Ambuja Cements: LIC acquired 3.99 crore equity shares in the company via open market transactions, increasing shareholding to 6.12% from 4.11% earlier.
Orissa Minerals Development Company: LIC sold 1.24 lakh equity shares in the company via open market transactions, reducing shareholding to 9.08% from 11.16% earlier.
NIIT: U.S.-based Sutherland, a leading global digital transformation company, and StackRoute, an NIIT Venture, have entered into a partnership to launch an immersive training program designed to identify the right talent and develop them as high-quality full stack IT professionals, handling critical roles at Sutherland.
Balaji Amines: The company’s demethylformamide plant will remain shut for two-three weeks. An incident took place at the company’s unit III demethylformamide plant which caused leakages/breakdown. While rectifying this the company added some debottlenecking activities to increase capacity.
Source: Moneycontrol, Livemint,, Bloomberg, Investing
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL